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Introduction
etal-on-metal bearings for hip replacement are
gaining popularity as an alternative to the most
widely used bearing couple of metal on polyethyl-
ene1. The recent resurgence of hip resurfacing with the so-
called third and fourth generations of hip resurfacing arthro-
plasty devices has played a substantial role in the wider use of
metal-on-metal bearings2-4. Concerns about the wear of poly-
ethylene and the role of polyethylene wear debris in the pro-
cess of aseptic loosening have also increased the use of hard-
on-hard bearing couples.
However, wear still takes place with metal-on-metal
bearings, and there is concern about the relatively high levels
of metallic ions released into the body as a consequence. Co-
balt-chromium alloy is the metal used for metal-on-metal im-
plants and, while these elements are required for normal
biological function, high concentrations of cobalt and chro-
mium are toxic and are known to interfere with a number of
biological processes5,6. The metal ion levels typically seen in
patients with well-functioning metal-on-metal implants are
not thought to be close to toxic levels7 and in many instances
are not much higher than those in patients with metal-on-
polyethylene implants8. However, there is a potential for much
higher concentrations of metal wear products in the joint fluid
in the vicinity of the bearing surfaces of poorly functioning
metal-on-metal implants. It is these very high levels that are
thought to be responsible for adverse reactions such as
osteolysis9 and the formation of soft-tissue masses10,11 and that
give rise to metallosis (defined as gray discoloration of the hip
joint)12. It is not clear whether the levels of metal ions mea-
sured in blood serum are indicative of the metal ion concen-
trations in the joint fluid. Perhaps more importantly, the
serum concentrations that are indicative of problems occur-
ring with the bearing and high levels in the joint fluid and tis-
sues have not been defined.
Detection of wear in metal-on-polyethylene couples is
possible with use of radiographic methods to measure the
penetration of the head into the polyethylene. This is not pos-
sible with metal-on-metal bearings. It is important to know if
excessive wear is occurring, and this will play a key role in the
management of patients who have a hip replacement. While it
is accepted that metal ion measurements are important for
monitoring metal-on-metal hip replacements13, a relation-
ship between serum metal ion levels and wear has not been
defined.
In the current study, we attempted to determine if mea-
surement of serum ion levels could be used as a diagnostic
tool by correlating blood and joint fluid metal-ion measure-
ments with findings of metallosis and component wear at re-
vision arthroplasty.
Materials and Methods
Patients
lood samples were collected from twenty-six consecutive
patients with a metal-on-metal hip replacement, which
was unilateral in nineteen and bilateral in seven, who were
scheduled for a revision arthroplasty. The patients with a bi-
lateral replacement were scheduled for revision on only one
side. The blood was collected from most patients on the day of
the revision, with the timing of the collection ranging from
zero to seven days prior to the revision. All revisions were per-
formed by one surgeon (K.D.S.). Hip joint fluid was collected
and the presence or absence of metallosis was recorded during
the revision procedure. The removed components were re-
tained to measure the amount of wear when possible.
The underlying diagnoses leading to the primary sur-
gery were osteoarthritis (85% of the patients), dysplasia
(11%), and osteonecrosis (4%). The mean age at the time of
the revision was 52.8 years (range, eighteen to seventy-four
years). There were seven men and nineteen women. The pri-
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mary metal-on-metal devices used in the series included both
hip resurfacing arthroplasty devices and total hip arthroplasty
devices. There were sixteen Birmingham hip resurfacing
devices (Smith and Nephew, Memphis, Tennessee), three Ar-
ticular Surface Replacement (ASR) hip resurfacing devices
(DePuy, Warsaw, Indiana), and one Durom hip resurfacing
device (Zimmer, Warsaw, Indiana). Three patients had an
M2a device (Biomet, Warsaw, Indiana) and one patient had a
Metasul couple, with an ExpanSys cup and a Zweymüller stem
(Mathys Orthopaedics, Bettlach, Switzerland); these total hip
arthroplasty devices all had a 28-mm head size. Two patients
had a combination of a resurfacing cup and a large modular
head: one had a Durom cup with a modular head on a VerSys
stem (Zimmer), and the other had an ASR cup with a modu-
lar head on a Corail stem (DePuy). The femoral head diame-
ters of the resurfacings and large modular head devices ranged
from 38 to 58 mm.
The average time of the implant in situ prior to the revi-
sion was 2.9 years (range, 0.5 to 8.4 years). The reasons for the
revision were a malpositioned component(s) in eighteen pa-
tients (fourteen with a malpositioned cup only, one with a
malpositioned head only, and three with malpositioning of
both components), osteolysis in three, a loose femoral compo-
nent in two, a loose cup in two, and a fractured total hip ar-
throplasty stem in one.
Methods
Blood samples were taken with use of an intravenous catheter
(Insyte-W; Becton Dickinson, Franklin Lakes, New Jersey).
After the catheter was introduced, the metal needle was with-
drawn and the first 5 mL of blood was discarded to avoid pos-
sible metal contamination from the needle. A second 5 mL of
blood was then collected with use of a vacuum tube (Venosafe
VF-106SAHL; Terumo Europe, Leuven, Belgium).
Hip joint fluid was collected, with use of a disposable
plastic 5-mL syringe (Becton Dickinson), after the joint was
exposed.
Serum and joint fluid levels of cobalt and chromium
were measured with use of an inductively-coupled plasma
mass spectrometry (ICP-MS) technique (ELAN DRC II;
PerkinElmer Life and Analytical Sciences, Waltham, Massa-
chusetts). These measurements were performed by the Labo-
ratory of Clinical Biology at Ghent University Hospital,
Ghent, Belgium. This laboratory quotes its quantification
limit as 0.5 µg/L with a reproducibility of 5%.
Wear measurements were performed with use of a coor-
dinate measuring machine (BRT 504; Mitutoyo America, Au-
rora, Illinois) to record the shape of the implant from 400
measurements with a resolution limit of 0.5 µm. The maxi-
mum depth of each wear scar, in micrometers, was used in the
analyses as the measure of wear.
Analyses
The serum and hip fluid metal-ion levels were compared be-
tween the patients with a unilateral replacement and those
with a bilateral replacement. The data were examined for dis-
tribution and were found to be non-normally distributed. The
Mann-Whitney U test was used to examine the differences in
distribution between the patients with a unilateral replace-
ment and those with a bilateral replacement.
The Mann-Whitney U test was used to compare the se-
rum and joint fluid metal-ion levels and femoral component
wear between the patients in whom metallosis was found dur-
ing revision and those in whom it was not.
The data on the patients with a unilateral replacement
were used to analyze the relationships between the serum
and joint fluid levels and the maximum depth of femoral
wear, as it was thought that bilateral implantation would af-
fect serum levels. The correlations between these values
were examined by calculating the correlation coefficient.
Robust regression analysis was applied to the data; the se-
rum levels were considered to be the independent variable,
and the joint fluid levels and wear measurements were con-
sidered to be the dependent variables. The standard method
of least-squares regression is very sensitive to outliers in the
data to be analyzed. In order to reduce the sensitivity of the
regression analysis to outliers, a bisquare weight scheme
was implemented. This scheme minimizes a weighted sum
of squares, with the weight given to each data point de-
pending on how far the point is from the fitted line. Points
near the line are given full weight. Points farther from the
line are given reduced weight. Points that are farther from
the line than would be expected by random chance are
given zero weight. The robust regression analysis was used
to fit both linear and exponential curves to the serum and
joint fluid metal-ion levels. The form of the linear equa-
tions was y = mx + c, whereas that for the exponential
equations was y = aebx. The developed regression equations
TABLE I Serum and Joint Fluid Metal-Ion Concentrations for the Entire Study Cohort (N = 26) 
Variable Median Minimum Maximum Interquartile Range
Serum chromium level (µg/L) 13.2 0.4 93 27.7
Serum cobalt level (µg/L) 5.8 1 94 22.65
Joint fluid chromium level (µg/L) 252 19 29,080 2142
Joint fluid cobalt level (µg/L) 201 13 5120 1399.2
Ratio of fluid to serum chromium level 47.4 10.5 394.4 59.46
Ratio of fluid to serum cobalt level 36.5 8.3 699.1 42.7
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were then applied to the serum data for the patients with a
bilateral arthroplasty; the predicted values for the hip joint
fluid levels were compared with the actual measured values.
Linear regression equations relating serum levels to wear
were used to predict wear values for the serum data for the
patients with a bilateral arthroplasty, which were again
compared with the actual measured values. Two types of
linear fit were developed for the serum levels and wear data;
the first was unconstrained, and the second was con-
strained to go through zero (i.e., c = 0).
Robust regression analysis was performed with use of
the Curve Fitting Toolbox (version 1.1) within the MATLAB
software environment (version 6.5; The MathWorks, Natick,
Massachusetts).
Results
he joint fluid levels of metal ions were at least an order of
magnitude higher than those measured in the serum (Fig.
1). In the whole cohort, the median ratio of the joint fluid
chromium level to the serum chromium level was 47.4 (range,
10.5 to 394.4) and the median ratio of the joint fluid cobalt
level to the serum cobalt level was 36.5 (range, 8.3 to 699.1)
(Table I).
The median serum and joint fluid levels of chromium
in the patients with a bilateral arthroplasty (17.7 µg/L
[range, 1.1 to 82.2 µg/L] and 333.0 µg/L [range, 32.2 to
6464.0 µg/L], respectively) were higher than those in the
patients with a unilateral arthroplasty (9.4 µg/L [range, 0.4
to 93.0 µg/L] and 201.0 µg/L [range, 19.0 to 29,080.0 µg/
T
TABLE II Differences Between Patients without and with Metallosis Found at Revision
Variable
Without Metallosis With Metallosis
Median Minimum Maximum
Interquartile 
Range Median Minimum Maximum
Interquartile 
Range P Value
Serum chromium 
level (µg/L)
3.35 0.4 21.5 13.58 33.9 5.3 93 40.4 0.001
Serum cobalt 
level (µg/L)
3.2 1 14 4.53 33.8 4.3 94 40.88 <0.001
Joint fluid chromium 
level (µg/L)
179.5 19 661 240.23 5136.5 155 29,080 16,264.25 0.001
Joint fluid cobalt 
level (µg/L)
106.25 13 769 165.3 2185 110 5120 2270.75 0.001
Femoral wear (µm) 10 2 36 18.3 49.5 7 184 41.25 0.002
Fig. 1
Differences in serum and joint fluid metal-ion concentrations for nineteen patients with a unilateral replacement and seven with a bilateral replace-
ment. The interquartile range is shown as a box, containing a horizontal line indicating the median.  The error bars indicate the extreme values 
within 1.5 times the interquartile range, and the plus symbols indicate outliers.
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L]). Conversely, the median serum and joint fluid levels of
cobalt in the patients with a bilateral arthroplasty (5.3 µg/L
[range, 1.4 to 62.7 µg/L] and 153.0 µg/L [range, 38.4 to
2423.0 µg/L], respectively) were lower than the median lev-
els in those with a unilateral arthroplasty (6.9 µg/L [range,
1.0 to 94.0 µg/L] and 235.0 µg/L [range, 13.0 to 5120.0 µg/
L]). With the number of subjects studied, these differences
were not significant.
It was possible to perform wear measurements on nine-
teen femoral components, of which fifteen were from patients
with a unilateral arthroplasty. Wear measurements were avail-
able for all ten patients in whom metallosis had been observed
during the revision surgery and for nine of the patients with-
out metallosis. The median serum chromium (p = 0.001) and
cobalt (p < 0.001) levels in the patients with metallosis were
approximately ten times higher than those in the patients
without metallosis (Fig. 2, Table II). The median joint fluid
chromium level was twenty-eight times higher (p = 0.001)
and the median joint fluid cobalt level was twenty times
higher (p = 0.001) in the patients with metallosis. Femoral
component wear in the patients with metallosis was approxi-
mately five times greater than that in the patients without
metallosis (p = 0.002).
There was a very high correlation between the serum
and joint fluid metal concentrations (of both chromium and
cobalt) (Fig. 3). For the patients with a unilateral arthroplasty,
the correlation coefficients were 0.92 for chromium and 0.88
for cobalt, and these were highly significant (p < 0.001 for
both chromium and cobalt). In the entire cohort of twenty-six
patients, these correlations were also high (0.82 for chro-
mium and 0.89 for cobalt) and significant (p < 0.001 for both
chromium and cobalt).
There were strong and significant correlations between
femoral component wear and serum metal levels (Fig. 4), with
correlation coefficients of 0.92 for chromium and 0.82 for co-
balt (p < 0.001 for both chromium and cobalt). There were
also high correlations between femoral component wear and
joint fluid metal levels, with correlation coefficients of 0.89 for
chromium and 0.88 for cobalt (p < 0.001 for both chromium
and cobalt).
Both linear and exponential curves showed reasonable
fits to the serum and joint fluid metal-ion-level data (Fig. 3).
The fit parameters (m and c for the linear curves, and a and b
for the exponential curves) were calculated with lower and up-
per 95% confidence intervals, which are given in parentheses
for the following values. For chromium, the linear fit gave m =
326.5 (271, 382) and c = −1323 (–3022, 375.5), and the R2
value was 0.899. The exponential fit gave a = 48.14 (35.7,
60.58) and b = 0.124 (–0.335, 0.583), with an R2 value of
0.959. For cobalt, the linear fit gave m = 39.5 (33.56, 45.44)
and c = –36.8 (–221.6, 148), and the R2 value was 0.954. The
exponential fit gave a = 88.72 (45.6, 131.9) and b = 0.058
(0.038, 0.079), with an R2 value of 0.939.
When the regression equations were applied to the se-
rum levels in the patients with a bilateral arthroplasty, the me-
dian errors in predicted hip-joint-fluid levels of chromium
were 3795.1 µg/L (range, 551.4 to 19,053.0 µg/L) from the lin-
ear fit and 182.1 µg/L (range, 23.0 µg/L to 1.26 × 106 µg/L)
Fig. 2
Differences in serum and joint fluid metal-ion concentrations and femoral component wear between the patients with and those without metallosis 
found at revision. The interquartile range is shown as a box, containing a horizontal line indicating the median.  The error bars indicate the extreme 
values within 1.5 times the interquartile range, and the plus symbols indicate outliers.
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from the exponential fit. The median errors in predicted hip-
joint-fluid levels of cobalt were 50.7 µg/L (range, 12.0 to 275.0
µg/L) from the linear fit and 59.0 µg/L (range, 18.5 to 1034.6
µg/L) from the exponential fit.
Both unconstrained and constrained linear regressions
provided reasonable fits to the serum metal-ion and femoral
component wear data (Fig. 4). For chromium levels and wear,
the unconstrained linear fit gave m = 1.04 (0.67, 1.42) and c =
7.05 (–5.83, 19.94) and the R2 value was 0.88; the constrained
linear fit gave m = 1.26 (1.00, 1.51), with an R2 value of 0.88.
For cobalt levels, the unconstrained linear fit gave m = 0.98
(0.65, 1.30) and c = 9.95 (–1.25, 21.15) and the R2 value was
0.90; the constrained fit gave m = 1.24 (0.99, 1.50), with an R2
value of 0.88.
When the regression equations were applied to the se-
rum chromium levels in the patients with a bilateral arthro-
plasty, the median errors in predicted femoral component
wear were 10.61 µm (range, 1.21 to 26.63 µm) from the un-
constrained linear fit and 8.44 µm (range, 1.86 to 37.37 µm)
from the constrained fit. The median errors in predicted fem-
oral component wear from the serum cobalt levels in the pa-
tients with a bilateral arthroplasty were 7.79 µm (range, 1.51
to 13.12 µm) from the unconstrained linear fit and 6.3 µm
(range, 0.33 to 17.17 µm) from the constrained fit.
Discussion
he concentrations of chromium and cobalt in the joint
fluid of patients with a metal-on-metal device can reachT
Fig. 3
Linear and exponential fits to the relationships between joint fluid and serum metal-ion concentrations. Only data for the nineteen patients with a 
unilateral arthroplasty were used to develop the regression lines.
Fig. 4
Unconstrained and constrained linear fits to the relationships between femoral component wear and serum metal-ion concentrations. Only data for 
the fifteen patients with a unilateral arthroplasty and for whom wear measurements were available were used to develop the regression lines.
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extremely high values, which are at least an order of magni-
tude higher than those measured in the serum. However, our
data clearly show a strong correlation between measured se-
rum and joint fluid concentrations of metal ions. Moreover,
we found surprisingly strong and highly significant correla-
tions between the maximum wear-scar depth and the metal
ion concentrations in both serum and joint fluid. Higher se-
rum and joint fluid metal-ion concentrations as well as higher
wear were significantly associated with the finding of metallo-
sis during revision. The lowest value of the interquartile range
for the serum metal-ion concentrations in these patients (17
µg/L for the chromium level and 19 µg/L for the cobalt level)
represents the level above which metallosis is highly likely to
be present. It should be noted that the average time that the
implant was in situ was 2.9 years in our series of patients and
that perhaps lower metal concentrations over a longer period
in situ will also result in metallosis.
It was interesting that there was no significant difference
in the median serum metal-ion level between the patients with
a unilateral arthroplasty and those with a bilateral arthro-
plasty in our study. This finding is probably due to the fact
that the much greater amount of ions originating from the
poorly functioning implants in the bilateral cases dominated
the overall serum measurement; however, the relatively small
number of subjects in the study could also account for the
finding.
We were able to construct both linear and exponential
relationships between serum and hip-joint-fluid metal-ion
concentrations. The relationship between serum and joint
fluid chromium levels appeared to be exponential, but there
were relatively few data points with high values for the joint
fluid metal-ion levels. Even with use of robust methods, the
exponential data fit was susceptible to outlier data points.
However, the linear fit still provides a reasonable estimate,
and probably this fit is less sensitive to the outlier values. In
terms of predicting joint fluid concentrations from serum
concentrations, the exponential relationship was better, but
the error increased dramatically for high serum values. The
relationship between serum and joint fluid cobalt concentra-
tions was found to be less clearly exponential; the linear fit
was better able to predict joint fluid concentrations from se-
rum values. For the linear fits, the confidence intervals for
the gradients were considerably smaller than those for the
intercepts. The joint fluid level of chromium was found to be
approximately fifty times the serum level, whereas the joint
fluid level of cobalt was approximately forty times the serum
level.
A surprising outcome was that both serum chromium
and serum cobalt levels were strongly correlated with our
measure of femoral component wear. A limitation of our
study is that we could only reasonably quantify wear by mea-
suring the maximum depth of the wear scar and we could not
reliably measure volumetric wear. We would have expected a
weaker relationship than the one that we found; it seems to
be logical that volumetric wear would be more closely related
to the metal ion concentration than would a linear measure
of wear. However, we can speculate that wear is highly local-
ized in metal-on-metal couples, strongly suggesting that
edge-loading is the dominant wear-generation mechanism.
This underlines the importance of proper positioning of all
types of metal-on-metal hip replacement devices.
Another limitation of the study is that the joint fluid was
obtained after the joint was exposed, making contamination
of the joint fluid by blood highly probable. In retrospect, the
joint fluid should have been collected by aspiration prior to
opening the joint. We therefore expect that the actual relation-
ships between serum and joint fluid metal-ion concentrations
are stronger than the ones that we found.
The clinical message from this study is that metal-ion
measurement is a valuable additional tool for diagnosis and
patient follow-up. We advocate routine measurement of se-
rum metal-ion levels during the care of patients with a
metal-on-metal device. In this series of patients undergoing
revision arthroplasty, there was not a single case in which a
high serum metal-ion concentration was not associated
with a high joint fluid metal-ion concentration and a high
wear value. The implication is that when high serum metal-
ion measurements are recorded there may be a problem
with the implant and the patient should be closely moni-
tored. We found a strong association between high serum
and joint fluid levels of chromium and cobalt and a finding
of metallosis at revision, an observation that supports the
use of metal-ion measurements as a diagnostic screening
test. Early revision of a metal-on-metal prosthesis in a pa-
tient with high serum metal-ion levels may help to avoid
metallosis and its associated problems9,10,12,14. In our experi-
ence, patients in whom the joint tissues are severely affected
by metallosis (for example, those with extensive synovitis,
expanded bursae with large volumes of discolored fluid,
and osseous changes such as femoral neck narrowing or
osteolysis) require a more thorough débridement during
revision surgery, which can result in a higher risk of postre-
vision complications such as dislocation15. Conversely, pa-
tients with well-positioned implants and low metal-ion
levels are likely to be at a low risk for metallosis and can be
monitored less frequently. If a patient with a bilateral re-
placement has high serum metal-ion values and no conclu-
sive diagnosis can be made on the basis of the radiographic
evaluation, performing a joint aspiration and measuring
metal ion concentrations in the joint fluid may enable one
to determine the side on which the implant is functioning
poorly and that requires closer monitoring.
In conclusion, measurements of serum ion concentra-
tions of chromium and cobalt can be used to estimate the
amount of wear taking place in metal-on-metal hip-replace-
ment devices. Serum metal-ion measurements are important
for the clinical management of patients with metal-on-metal
implants and should be routinely performed. Patients present-
ing with high serum metal-ion levels should be closely moni-
tored, as early revision may be necessary. Finally, serum
chromium-ion levels of >17 µg/L and serum cobalt-ion levels
of >19 µg/L are more likely to be associated with metallosis. 
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